These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2882970)

  • 1. Dose-dependent pharmacokinetics of ibuprofen in the rat.
    Shah A; Jung D
    Drug Metab Dispos; 1987; 15(2):151-4. PubMed ID: 2882970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.
    Bredberg U; Paalzow L
    Drug Metab Dispos; 1990; 18(3):338-43. PubMed ID: 1974196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ibuprofen in lactating dairy cows.
    DeGraves FJ; Anderson KL; Aucoin DP
    Am J Vet Res; 1993 Jul; 54(7):1133-5. PubMed ID: 8368610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
    Bortolotti A; Jiritano L; Bonati M
    Drug Metab Dispos; 1985; 13(2):227-31. PubMed ID: 2859173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL; Varma DR
    Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
    Mehta SC; Boudinot FD; Lu DR
    Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nutritional status on the pharmacokinetics and pharmacodynamics of pentobarbital.
    Jung D; Prasad PP
    Drug Metab Dispos; 1989; 17(4):365-8. PubMed ID: 2571473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat.
    Miller RP; Rotenberg KS; Adir J
    Drug Metab Dispos; 1977; 5(5):436-43. PubMed ID: 20291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.
    Aungst BJ; Blake JA; Rogers NJ; Dusak BA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):230-6. PubMed ID: 2329509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat.
    Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S
    Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.